E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 11/17/2005 in the Prospect News Biotech Daily.

Hypertension Diagnostics extends warrants, cuts exercise price

New York, Nov. 17 - Hypertension Diagnostics, Inc. said it has extended the expiration of its redeemable class B warrants to Feb. 28, 2006 from Jan. 23, 2006 and lower the exercise price to $0.22 per share from $1.00.

The warrants were issued on the exercise of redeemable class A warrants during 2001 and 2002. The class A warrants were issued in the company's initial public offering in 1998.

Hypertension Diagnostics is an Eagan, Minn., maker of blood pressure waveform analysis equipment.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.